ÂÜÀòÂÒÂ×

Dr. Liz Dallimore is a medical and biotechnology executive currently serving as Co-Founder and Executive Chairman of Inspiring Holdings Pty Ltd, a company specializing in proprietary inhalation technology. As CEO and Managing Director of Argenica Therapeutics, Dr. Dallimore oversees the development of novel neuroprotective therapies for brain injuries. Involved in various leadership roles, Dr. Dallimore is also a Board Director for the Chamber of Commerce and Industry WA, AusBiotech, and previously served on the Board of NERA. With a strong background in research and commercialization from KPMG and experience in academia, Dr. Dallimore holds multiple degrees, including a PhD in Neuroscience from The University of Western Australia, and an MBA from AGSM @ UNSW Business School.